﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:trackback="http://madskills.com/public/xml/rss/module/trackback/">
  <channel>
    <title>Marc Ullman - FYI Blog</title>
    <description>&lt;img src="http://www.npicenter.com/images/MarcUllman.gif" border="0" align="left" hspace="5" vspace="5"&gt;Mr. Ullman speaks frequently on various regulatory matters at various events, including Virgo Publications' Natural Products Industry Supply Side West Trade Shows and the National Nutritional Foods Association's annual MarketPlace Convention.  He also manages the FYI Newsletter highlighting legal and regulatory issues concerning the Natural Product Industry.  &lt;br&gt;&lt;br&gt;Marc is a partner in New York City based Ullman, Shapiro &amp; Ullman, &lt;a href="http://www.usulaw.com" target="_blank"&gt;www.usulaw.com&lt;/a&gt;. You can contact him at Marc[at]usulaw.com&lt;br&gt;&lt;br&gt;&lt;i&gt;Please note that blog is not intended to provide or serve as legal advice of any kind, and that the reader should not rely on it for such advice.&lt;/i&gt;  </description>
    <link>http://blogs.npicenter.com/Blogs/tabid/37/BlogId/2/Default.aspx</link>
    <language>en-US</language>
    <managingEditor>marc@usulaw.com</managingEditor>
    <webMaster>len.monheit@penton.com</webMaster>
    <pubDate>Fri, 20 Nov 2009 16:37:44 GMT</pubDate>
    <lastBuildDate>Fri, 20 Nov 2009 16:37:44 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>Blog RSS Generator Version 3.5.1.19887</generator>
    <item>
      <title>GSK vs. The Supplement Industry:  Who Wins?</title>
      <description>&lt;p class="MsoNormal" style="margin: 0in 0in 0pt"&gt;&lt;font size="3" face="Times New Roman"&gt;FDA receives “32 reports of liver injury including 27 requiring hospitalization” in users of GlaxoSmithKline’s Alli OTC weight loss drug.&lt;span style="mso-spacerun: yes"&gt;  &lt;/span&gt;FDA receives 23 reports of liver injury including one death in users of the dietary supplement Hydroxycut.&lt;span style="mso-spacerun: yes"&gt;  &lt;/span&gt;Guess which one is still on the market.&lt;/font&gt;&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Blogs/tabid/37/EntryId/67/GSK-vs-The-Supplement-Industry-Who-Wins.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/67/GSK-vs-The-Supplement-Industry-Who-Wins.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/67/GSK-vs-The-Supplement-Industry-Who-Wins.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Blogs/tabid/37/EntryId/67/GSK-vs-The-Supplement-Industry-Who-Wins.aspx</guid>
      <pubDate>Wed, 26 Aug 2009 20:34:00 GMT</pubDate>
      <slash:comments>4</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=67</trackback:ping>
    </item>
    <item>
      <title>Healthcare Industry vs. Supplement Industry:  Who wins?</title>
      <description>&lt;p&gt;The Wall Street Journal reports that industry affected by proposed health-care reform spent $133 million lobbying on the issue before Congress last quarter. How do you think the supplement industry stacks up?&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Blogs/tabid/37/EntryId/65/Healthcare-Industry-vs-Supplement-Industry-Who-wins.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/65/Healthcare-Industry-vs-Supplement-Industry-Who-wins.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/65/Healthcare-Industry-vs-Supplement-Industry-Who-wins.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Blogs/tabid/37/EntryId/65/Healthcare-Industry-vs-Supplement-Industry-Who-wins.aspx</guid>
      <pubDate>Wed, 05 Aug 2009 17:07:00 GMT</pubDate>
      <slash:comments>3</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=65</trackback:ping>
    </item>
    <item>
      <title>Biting the Hand that Feeds You</title>
      <description>&lt;p&gt;The &lt;em&gt;Washington Post&lt;/em&gt; publishes an AP story slamming supplements.  Consumerlab.com supplies a quote warning consumers about quality problems in the industry.  What else is new?&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Blogs/tabid/37/EntryId/59/Biting-the-Hand-that-Feeds-You.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/59/Biting-the-Hand-that-Feeds-You.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/59/Biting-the-Hand-that-Feeds-You.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Blogs/tabid/37/EntryId/59/Biting-the-Hand-that-Feeds-You.aspx</guid>
      <pubDate>Wed, 10 Jun 2009 16:15:00 GMT</pubDate>
      <slash:comments>0</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=59</trackback:ping>
    </item>
    <item>
      <title>If You Subscribe to the LA Times, You Need to Read This</title>
      <description>&lt;p&gt;Does any dietary supplement offer any significant health benefit to humans?  According to the LA Times, the answer is "No"!&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Blogs/tabid/37/EntryId/58/If-You-Subscribe-to-the-LA-Times-You-Need-to-Read-This.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/58/If-You-Subscribe-to-the-LA-Times-You-Need-to-Read-This.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/58/If-You-Subscribe-to-the-LA-Times-You-Need-to-Read-This.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Blogs/tabid/37/EntryId/58/If-You-Subscribe-to-the-LA-Times-You-Need-to-Read-This.aspx</guid>
      <pubDate>Fri, 29 May 2009 15:25:00 GMT</pubDate>
      <slash:comments>0</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=58</trackback:ping>
    </item>
    <item>
      <title>Energy and Commerce Leaders Release Food Safety Enhancement Act of 2009 Draft</title>
      <description>&lt;p&gt;The working draft of the House version of the Food Safety Legislation has been relaeased.  The primary authors of the bill are Chairman Emeterius John D. Dingell, Chairs Henry A. Waxman, Frank Pallone, and Bart Stupak, and Reps. Diana DeGette and Betty Sutton.&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Blogs/tabid/37/EntryId/57/Energy-and-Commerce-Leaders-Release-Food-Safety-Enhancement-Act-of-2009-Draft.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/57/Energy-and-Commerce-Leaders-Release-Food-Safety-Enhancement-Act-of-2009-Draft.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/57/Energy-and-Commerce-Leaders-Release-Food-Safety-Enhancement-Act-of-2009-Draft.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Blogs/tabid/37/EntryId/57/Energy-and-Commerce-Leaders-Release-Food-Safety-Enhancement-Act-of-2009-Draft.aspx</guid>
      <pubDate>Wed, 27 May 2009 21:48:00 GMT</pubDate>
      <slash:comments>0</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=57</trackback:ping>
    </item>
    <item>
      <title>FDA Sends a Flurry of H1N1 Warning Letters  . . . . Sort of.</title>
      <description>&lt;p&gt;FDA recently send a number of warning letters to websites offering products purporting to be dietary supplements that can cure or prevent the H1N1 virus (swine flu).  The way those letters were addressed makes me wonder if the Agency really cares if they get there.&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Blogs/tabid/37/EntryId/55/FDA-Sends-a-Flurry-of-H1N1-Warning-Letters-Sort-of.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/55/FDA-Sends-a-Flurry-of-H1N1-Warning-Letters-Sort-of.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Blogs/tabid/37/EntryId/55/FDA-Sends-a-Flurry-of-H1N1-Warning-Letters-Sort-of.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Blogs/tabid/37/EntryId/55/FDA-Sends-a-Flurry-of-H1N1-Warning-Letters-Sort-of.aspx</guid>
      <pubDate>Tue, 26 May 2009 16:13:00 GMT</pubDate>
      <slash:comments>1</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=55</trackback:ping>
    </item>
    <item>
      <title>What's Coming at FDA?</title>
      <description>&lt;p&gt;&lt;span class="Normal" id="dnn_ctr441_MainView_ViewEntry_lblEntry"&gt;I'm a little concerned about what I found while working on an article trying to predict what dietary supplement regulation might look like under the Obama Administration.&lt;/span&gt;&lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Home/tabid/37/EntryId/32/Whats-Coming-at-FDA.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Home/tabid/37/EntryId/32/Whats-Coming-at-FDA.aspx</link>
      <author>marc@usulaw.com</author>
      <comments>http://blogs.npicenter.com/Home/tabid/37/EntryId/32/Whats-Coming-at-FDA.aspx#Comments</comments>
      <guid isPermaLink="true">http://blogs.npicenter.com/Home/tabid/37/EntryId/32/Whats-Coming-at-FDA.aspx</guid>
      <pubDate>Mon, 26 Jan 2009 21:20:00 GMT</pubDate>
      <slash:comments>0</slash:comments>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=32</trackback:ping>
    </item>
    <item>
      <title>Another Day, Another Recall</title>
      <description>&lt;p&gt; &lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Home/tabid/37/EntryId/30/Another-Day-Another-Recall.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Home/tabid/37/EntryId/30/Another-Day-Another-Recall.aspx</link>
      <author>marc@usulaw.com</author>
      <guid isPermaLink="true">http://blogs.npicenter.com/Home/tabid/37/EntryId/30/Another-Day-Another-Recall.aspx</guid>
      <pubDate>Wed, 30 Jul 2008 15:52:00 GMT</pubDate>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=30</trackback:ping>
    </item>
    <item>
      <title>Bayer Throuws Down A Gauntlet, What Will FDA Do?</title>
      <description>&lt;p&gt; &lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Home/tabid/37/EntryId/29/Bayer-Throuws-Down-A-Gauntlet-What-Will-FDA-Do.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Home/tabid/37/EntryId/29/Bayer-Throuws-Down-A-Gauntlet-What-Will-FDA-Do.aspx</link>
      <author>marc@usulaw.com</author>
      <guid isPermaLink="true">http://blogs.npicenter.com/Home/tabid/37/EntryId/29/Bayer-Throuws-Down-A-Gauntlet-What-Will-FDA-Do.aspx</guid>
      <pubDate>Tue, 20 May 2008 20:37:00 GMT</pubDate>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=29</trackback:ping>
    </item>
    <item>
      <title>Who Needs Competition Anyway?</title>
      <description>&lt;p&gt; &lt;/p&gt;&lt;a href=http://blogs.npicenter.com/Home/tabid/37/EntryId/28/Who-Needs-Competition-Anyway.aspx&gt;More...&lt;/a&gt;</description>
      <link>http://blogs.npicenter.com/Home/tabid/37/EntryId/28/Who-Needs-Competition-Anyway.aspx</link>
      <author>marc@usulaw.com</author>
      <guid isPermaLink="true">http://blogs.npicenter.com/Home/tabid/37/EntryId/28/Who-Needs-Competition-Anyway.aspx</guid>
      <pubDate>Fri, 09 May 2008 19:03:00 GMT</pubDate>
      <trackback:ping>http://blogs.npicenter.com/DesktopModules/Blog/Trackback.aspx?id=28</trackback:ping>
    </item>
  </channel>
</rss>